ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

Wittes, Fraumeni Appointed As Division Directors

February 9, 1996

Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website

August 8, 2014

The Tivozanib Timeline

May 10, 2013

In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow

June 16, 1995

In Brief: President Asks $700 Million for NCI In 1977; Appropriation Delay Halts New Research Funds

January 2, 1976

Cancer Letter Goes On Vacation

August 16, 1985